Financhill
Back

Y-mAbs Therapeutics Vs. REV Group Industry Stock Comparison

Sell
29

YMAB
Y-mAbs Therapeutics

Last Price:
10.01
Seasonality Move:
12.09%
Buy
74

REVG
REV Group

Last Price:
33.73
Seasonality Move:
2.81%
Sell
29
Y-mAbs Therapeutics (YMAB) is a Sell

Is Y-mAbs Therapeutics a Buy, Sell or Hold?

  • The current Y-mAbs Therapeutics [YMAB] share price is $10.01. The Score for YMAB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • YMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
REV Group (REVG) is a Buy

Is REV Group a Buy, Sell or Hold?

  • The current REV Group [REVG] share price is $33.69. The Score for REVG is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • REVG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

YMAB Stock Price Chart

What is Y-mAbs Therapeutics's stock price today?

  • The Y-mAbs Therapeutics share price today is $10.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing slight selling pressure.

REVG Stock Price Chart

What is REV Group's stock price today?

  • The REV Group share price today is $33.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVG is experiencing slight selling pressure.

YMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 32.47 Sell
Chaikin Money Flow: -71841 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.89 - 13.51) Sell
Bollinger Bands (100): (11.39 - 14.57) Sell

REVG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.68 Buy
Relative Strength Index (14 RSI): 65.86 Buy
Chaikin Money Flow: -681203 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.5 - 31.6) Buy
Bollinger Bands (100): (26.92 - 30.28) Buy

YMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.52 Sell
20-day SMA: 10.89 Sell
50-day SMA: 13.07 Sell
200-day SMA: 13.45 Sell
8-day EMA: 10.47 Sell
20-day EMA: 11.22 Sell
50-day EMA: 12.31 Sell
200-day EMA: 12.4 Sell

REVG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.23 Buy
20-day SMA: 30.66 Buy
50-day SMA: 29.04 Buy
200-day SMA: 26.02 Buy
8-day EMA: 31.23 Buy
20-day EMA: 30.62 Buy
50-day EMA: 29.53 Buy
200-day EMA: 25.93 Buy

Y-mAbs Therapeutics Earnings Growth & YMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.05 per share.

REV Group Earnings Growth & REVG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.14 per share, an increase this year of $0.41 per share, and an increase next year of $0.52 per share.

Y-mAbs Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

REV Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):